SidaGhanaV1, Main, Exploration, bibRecord, 000968

The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania

Identifieur interne : 000968 ( Main/Exploration ); précédent : 000967; suivant : 000969

The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania

Auteurs : S. Meschi [Italie] ; M. Sa É Schepisi [Italie] ; E. Nicastri [Italie] ; N. Bevilacqua [Italie] ; C. Castilletti [Italie] ; M. R. Sciarrone [Italie] ; M. G. Paglia [Italie] ; R. Fumakule [Tanzanie] ; J. Mohamed [Tanzanie] ; A. Kitwa [Tanzanie] ; S. Mangi [Tanzanie] ; F. Molteni [Italie] ; A. Di Caro [Italie] ; F. Vairo [Italie] ; M. R. Capobianchi [Italie] ; G. Ippolito [Italie]

Source :

Journal of Medical Virology [ 0146-6615 ] ; 2010-09.

RBID : ISTEX:686B7C444E0A315DDEF969C7C38680C6CB07F4EE

Descripteurs français

Wicri :
- geographic : Tanzanie.
- topic : Petite enfance, Recherche médicale, Population rurale.

English descriptors

Abstract

The aim of this study was to determine the seroprevalence of human herpesvirus 8 (HHV‐8) and the immunization status for hepatitis B virus (HBV) infection in febrile patients in two districts of the United Republic of Tanzania. Between February and March 2007, blood samples were collected in Pemba Island and Tosamaganga from 336 outpatients and sent to the Virology Laboratory in Rome (Italy) for testing. HHV‐8 DNA and HBV‐DNA were amplified by two in‐house molecular methods, anti‐HHV‐8 antibody titers were determined by an immunofluorescence assay (IFA), and anti‐HCV, HBsAg, anti‐HBs, and anti‐HBc were evaluated by microplate enzyme immunoassay (MEIA). The seroprevalence of HHV‐8 was 30.7% (96/313). In Pemba Island, the prevalence was lower than in Tosamaganga (14.4% vs. 46.3%). A higher prevalence of low titers of HHV‐8 IgG (<1:80, 81%) was found among those under 5 years of age. HHV‐8 DNA was detected in six seropositive patients (6.7%). The prevalence of HBsAg, anti‐HBs, and anti‐HBc was 4.3%, 37.6%, and 29.3%, respectively. Out of 277 patients, 70 had had a previous infection (25.3%). One case of occult hepatitis was found. The cover of hepatitis B vaccination was higher among children born after 2002 (66.7%) than in patients born before 2002. HHV‐8 infection is endemic in Tanzania and the seroprevalence rate was higher in the mainland than on Pemba Island. The 3.9% percentage of HBsAg in children younger than 4 years of age suggests that increased efforts are required in order to achieve universal and compulsory immunization of children against HBV. J. Med. Virol. 82:1569–1575, 2010. © 2010 Wiley‐Liss, Inc.

Url:

https://api.istex.fr/document/686B7C444E0A315DDEF969C7C38680C6CB07F4EE/fulltext/pdf

DOI: 10.1002/jmv.21852

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000400
to stream Istex, to step Curation: 000400
to stream Istex, to step Checkpoint: 000138
to stream Main, to step Merge: 000977
to stream Main, to step Curation: 000968

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania</title>
<author><name sortKey="Meschi, S" sort="Meschi, S" uniqKey="Meschi S" first="S." last="Meschi">S. Meschi</name>
</author>
<author><name sortKey="Schepisi, M Sa E" sort="Schepisi, M Sa E" uniqKey="Schepisi M" first="M. Sa É" last="Schepisi">M. Sa É Schepisi</name>
</author>
<author><name sortKey="Nicastri, E" sort="Nicastri, E" uniqKey="Nicastri E" first="E." last="Nicastri">E. Nicastri</name>
</author>
<author><name sortKey="Bevilacqua, N" sort="Bevilacqua, N" uniqKey="Bevilacqua N" first="N." last="Bevilacqua">N. Bevilacqua</name>
</author>
<author><name sortKey="Castilletti, C" sort="Castilletti, C" uniqKey="Castilletti C" first="C." last="Castilletti">C. Castilletti</name>
</author>
<author><name sortKey="Sciarrone, M R" sort="Sciarrone, M R" uniqKey="Sciarrone M" first="M. R." last="Sciarrone">M. R. Sciarrone</name>
</author>
<author><name sortKey="Paglia, M G" sort="Paglia, M G" uniqKey="Paglia M" first="M. G." last="Paglia">M. G. Paglia</name>
</author>
<author><name sortKey="Fumakule, R" sort="Fumakule, R" uniqKey="Fumakule R" first="R." last="Fumakule">R. Fumakule</name>
</author>
<author><name sortKey="Mohamed, J" sort="Mohamed, J" uniqKey="Mohamed J" first="J." last="Mohamed">J. Mohamed</name>
</author>
<author><name sortKey="Kitwa, A" sort="Kitwa, A" uniqKey="Kitwa A" first="A." last="Kitwa">A. Kitwa</name>
</author>
<author><name sortKey="Mangi, S" sort="Mangi, S" uniqKey="Mangi S" first="S." last="Mangi">S. Mangi</name>
</author>
<author><name sortKey="Molteni, F" sort="Molteni, F" uniqKey="Molteni F" first="F." last="Molteni">F. Molteni</name>
</author>
<author><name sortKey="Di Caro, A" sort="Di Caro, A" uniqKey="Di Caro A" first="A." last="Di Caro">A. Di Caro</name>
</author>
<author><name sortKey="Vairo, F" sort="Vairo, F" uniqKey="Vairo F" first="F." last="Vairo">F. Vairo</name>
</author>
<author><name sortKey="Capobianchi, M R" sort="Capobianchi, M R" uniqKey="Capobianchi M" first="M. R." last="Capobianchi">M. R. Capobianchi</name>
</author>
<author><name sortKey="Ippolito, G" sort="Ippolito, G" uniqKey="Ippolito G" first="G." last="Ippolito">G. Ippolito</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:686B7C444E0A315DDEF969C7C38680C6CB07F4EE</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/jmv.21852</idno>
<idno type="url">https://api.istex.fr/document/686B7C444E0A315DDEF969C7C38680C6CB07F4EE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000400</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000400</idno>
<idno type="wicri:Area/Istex/Curation">000400</idno>
<idno type="wicri:Area/Istex/Checkpoint">000138</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000138</idno>
<idno type="wicri:doubleKey">0146-6615:2010:Meschi S:the:prevalence:of</idno>
<idno type="wicri:Area/Main/Merge">000977</idno>
<idno type="wicri:Area/Main/Curation">000968</idno>
<idno type="wicri:Area/Main/Exploration">000968</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania</title>
<author><name sortKey="Meschi, S" sort="Meschi, S" uniqKey="Meschi S" first="S." last="Meschi">S. Meschi</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Virology, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Italie</country>
<wicri:regionArea>Laboratory of Virology, “L. Spallanzani” National Institute for Infectious Diseases, Via Portuense 292, 00149 Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schepisi, M Sa E" sort="Schepisi, M Sa E" uniqKey="Schepisi M" first="M. Sa É" last="Schepisi">M. Sa É Schepisi</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Epidemiology and Pre‐Clinical Research, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nicastri, E" sort="Nicastri, E" uniqKey="Nicastri E" first="E." last="Nicastri">E. Nicastri</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinical Department, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bevilacqua, N" sort="Bevilacqua, N" uniqKey="Bevilacqua N" first="N." last="Bevilacqua">N. Bevilacqua</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinical Department, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Castilletti, C" sort="Castilletti, C" uniqKey="Castilletti C" first="C." last="Castilletti">C. Castilletti</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Virology, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sciarrone, M R" sort="Sciarrone, M R" uniqKey="Sciarrone M" first="M. R." last="Sciarrone">M. R. Sciarrone</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Virology, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Paglia, M G" sort="Paglia, M G" uniqKey="Paglia M" first="M. G." last="Paglia">M. G. Paglia</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Microbiology and Biorepository, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fumakule, R" sort="Fumakule, R" uniqKey="Fumakule R" first="R." last="Fumakule">R. Fumakule</name>
<affiliation wicri:level="1"><country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>Tosamaganga Hospital, Iringa</wicri:regionArea>
<wicri:noRegion>Iringa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mohamed, J" sort="Mohamed, J" uniqKey="Mohamed J" first="J." last="Mohamed">J. Mohamed</name>
<affiliation wicri:level="1"><country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>“Ivo De Carneri” Public Health Laboratory, Pemba</wicri:regionArea>
<wicri:noRegion>Pemba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kitwa, A" sort="Kitwa, A" uniqKey="Kitwa A" first="A." last="Kitwa">A. Kitwa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>National Institute for Medical Research, Dar es Salaam</wicri:regionArea>
<wicri:noRegion>Dar es Salaam</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mangi, S" sort="Mangi, S" uniqKey="Mangi S" first="S." last="Mangi">S. Mangi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Tanzanie</country>
<wicri:regionArea>Tosamaganga Hospital, Iringa</wicri:regionArea>
<wicri:noRegion>Iringa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Molteni, F" sort="Molteni, F" uniqKey="Molteni F" first="F." last="Molteni">F. Molteni</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Italian Cooperation, Italian Ministry of Foreign Affairs, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Di Caro, A" sort="Di Caro, A" uniqKey="Di Caro A" first="A." last="Di Caro">A. Di Caro</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Microbiology and Biorepository, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vairo, F" sort="Vairo, F" uniqKey="Vairo F" first="F." last="Vairo">F. Vairo</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinical Department, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Capobianchi, M R" sort="Capobianchi, M R" uniqKey="Capobianchi M" first="M. R." last="Capobianchi">M. R. Capobianchi</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Virology, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ippolito, G" sort="Ippolito, G" uniqKey="Ippolito G" first="G." last="Ippolito">G. Ippolito</name>
<affiliation wicri:level="3"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Epidemiology and Pre‐Clinical Research, “L. Spallanzani” National Institute for Infectious Diseases, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Medical Virology</title>
<title level="j" type="alt">JOURNAL OF MEDICAL VIROLOGY</title>
<idno type="ISSN">0146-6615</idno>
<idno type="eISSN">1096-9071</idno>
<imprint><biblScope unit="vol">82</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1569">1569</biblScope>
<biblScope unit="page" to="1575">1575</biblScope>
<biblScope unit="page-count">7</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-09">2010-09</date>
</imprint>
<idno type="ISSN">0146-6615</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0146-6615</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abdominal pain</term>
<term>Active infection</term>
<term>Adult patients</term>
<term>African countries</term>
<term>African patients</term>
<term>Antibody titer</term>
<term>Antibody titers</term>
<term>Blood donors</term>
<term>Blood samples</term>
<term>Chake</term>
<term>Chake chake hospital</term>
<term>Chronic hepatitis</term>
<term>Clinical samples</term>
<term>Different regions</term>
<term>Early childhood</term>
<term>East africa</term>
<term>Endemic</term>
<term>Endemic population</term>
<term>Febrile patients</term>
<term>Febrile syndromes</term>
<term>Foreign affairs</term>
<term>General population</term>
<term>Hbsag</term>
<term>Hepatitis</term>
<term>Herpesvirus</term>
<term>Higher prevalence</term>
<term>Higher seroprevalence</term>
<term>Human herpesvirus</term>
<term>Human virus</term>
<term>Immunization</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Italian cooperation</term>
<term>Italian ministry</term>
<term>Joint pain</term>
<term>Joint pain headache</term>
<term>Logical approach</term>
<term>Mass immunization</term>
<term>Medical research</term>
<term>Multicentric disease</term>
<term>National bureau</term>
<term>National institute</term>
<term>Northern cameroon</term>
<term>Occult hepatitis</term>
<term>Pemba</term>
<term>Pemba hospital</term>
<term>Pemba island</term>
<term>Prevalence</term>
<term>Prevalence rate</term>
<term>Previous data</term>
<term>Previous infection</term>
<term>Public health laboratory</term>
<term>Risk factors</term>
<term>Rural population</term>
<term>Rural tanzania</term>
<term>Seroepidemiological studies</term>
<term>Seropositive patients</term>
<term>Seroprevalence</term>
<term>Seroprevalence rate</term>
<term>Serum samples</term>
<term>Sexual activity</term>
<term>Sexual transmission</term>
<term>Spallanzani</term>
<term>Tanzania</term>
<term>Titer</term>
<term>Tosamaganga</term>
<term>Tosamaganga hospital</term>
<term>Venous blood</term>
<term>Viral load</term>
<term>Virol</term>
<term>West africa</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abdominal pain</term>
<term>Active infection</term>
<term>Adult patients</term>
<term>African countries</term>
<term>African patients</term>
<term>Antibody titer</term>
<term>Antibody titers</term>
<term>Blood donors</term>
<term>Blood samples</term>
<term>Chake</term>
<term>Chake chake hospital</term>
<term>Chronic hepatitis</term>
<term>Clinical samples</term>
<term>Different regions</term>
<term>Early childhood</term>
<term>East africa</term>
<term>Endemic</term>
<term>Endemic population</term>
<term>Febrile patients</term>
<term>Febrile syndromes</term>
<term>Foreign affairs</term>
<term>General population</term>
<term>Hbsag</term>
<term>Hepatitis</term>
<term>Herpesvirus</term>
<term>Higher prevalence</term>
<term>Higher seroprevalence</term>
<term>Human herpesvirus</term>
<term>Human virus</term>
<term>Immunization</term>
<term>Infection</term>
<term>Infectious diseases</term>
<term>Italian cooperation</term>
<term>Italian ministry</term>
<term>Joint pain</term>
<term>Joint pain headache</term>
<term>Logical approach</term>
<term>Mass immunization</term>
<term>Medical research</term>
<term>Multicentric disease</term>
<term>National bureau</term>
<term>National institute</term>
<term>Northern cameroon</term>
<term>Occult hepatitis</term>
<term>Pemba</term>
<term>Pemba hospital</term>
<term>Pemba island</term>
<term>Prevalence</term>
<term>Prevalence rate</term>
<term>Previous data</term>
<term>Previous infection</term>
<term>Public health laboratory</term>
<term>Risk factors</term>
<term>Rural population</term>
<term>Rural tanzania</term>
<term>Seroepidemiological studies</term>
<term>Seropositive patients</term>
<term>Seroprevalence</term>
<term>Seroprevalence rate</term>
<term>Serum samples</term>
<term>Sexual activity</term>
<term>Sexual transmission</term>
<term>Spallanzani</term>
<term>Tanzania</term>
<term>Titer</term>
<term>Tosamaganga</term>
<term>Tosamaganga hospital</term>
<term>Venous blood</term>
<term>Viral load</term>
<term>Virol</term>
<term>West africa</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Tanzanie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Petite enfance</term>
<term>Recherche médicale</term>
<term>Population rurale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The aim of this study was to determine the seroprevalence of human herpesvirus 8 (HHV‐8) and the immunization status for hepatitis B virus (HBV) infection in febrile patients in two districts of the United Republic of Tanzania. Between February and March 2007, blood samples were collected in Pemba Island and Tosamaganga from 336 outpatients and sent to the Virology Laboratory in Rome (Italy) for testing. HHV‐8 DNA and HBV‐DNA were amplified by two in‐house molecular methods, anti‐HHV‐8 antibody titers were determined by an immunofluorescence assay (IFA), and anti‐HCV, HBsAg, anti‐HBs, and anti‐HBc were evaluated by microplate enzyme immunoassay (MEIA). The seroprevalence of HHV‐8 was 30.7% (96/313). In Pemba Island, the prevalence was lower than in Tosamaganga (14.4% vs. 46.3%). A higher prevalence of low titers of HHV‐8 IgG (<1:80, 81%) was found among those under 5 years of age. HHV‐8 DNA was detected in six seropositive patients (6.7%). The prevalence of HBsAg, anti‐HBs, and anti‐HBc was 4.3%, 37.6%, and 29.3%, respectively. Out of 277 patients, 70 had had a previous infection (25.3%). One case of occult hepatitis was found. The cover of hepatitis B vaccination was higher among children born after 2002 (66.7%) than in patients born before 2002. HHV‐8 infection is endemic in Tanzania and the seroprevalence rate was higher in the mainland than on Pemba Island. The 3.9% percentage of HBsAg in children younger than 4 years of age suggests that increased efforts are required in order to achieve universal and compulsory immunization of children against HBV. J. Med. Virol. 82:1569–1575, 2010. © 2010 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations><list><country><li>Italie</li>
<li>Tanzanie</li>
</country>
<region><li>Latium</li>
</region>
<settlement><li>Rome</li>
</settlement>
</list>
<tree><country name="Italie"><region name="Latium"><name sortKey="Meschi, S" sort="Meschi, S" uniqKey="Meschi S" first="S." last="Meschi">S. Meschi</name>
</region>
<name sortKey="Bevilacqua, N" sort="Bevilacqua, N" uniqKey="Bevilacqua N" first="N." last="Bevilacqua">N. Bevilacqua</name>
<name sortKey="Capobianchi, M R" sort="Capobianchi, M R" uniqKey="Capobianchi M" first="M. R." last="Capobianchi">M. R. Capobianchi</name>
<name sortKey="Castilletti, C" sort="Castilletti, C" uniqKey="Castilletti C" first="C." last="Castilletti">C. Castilletti</name>
<name sortKey="Di Caro, A" sort="Di Caro, A" uniqKey="Di Caro A" first="A." last="Di Caro">A. Di Caro</name>
<name sortKey="Ippolito, G" sort="Ippolito, G" uniqKey="Ippolito G" first="G." last="Ippolito">G. Ippolito</name>
<name sortKey="Meschi, S" sort="Meschi, S" uniqKey="Meschi S" first="S." last="Meschi">S. Meschi</name>
<name sortKey="Molteni, F" sort="Molteni, F" uniqKey="Molteni F" first="F." last="Molteni">F. Molteni</name>
<name sortKey="Nicastri, E" sort="Nicastri, E" uniqKey="Nicastri E" first="E." last="Nicastri">E. Nicastri</name>
<name sortKey="Paglia, M G" sort="Paglia, M G" uniqKey="Paglia M" first="M. G." last="Paglia">M. G. Paglia</name>
<name sortKey="Schepisi, M Sa E" sort="Schepisi, M Sa E" uniqKey="Schepisi M" first="M. Sa É" last="Schepisi">M. Sa É Schepisi</name>
<name sortKey="Sciarrone, M R" sort="Sciarrone, M R" uniqKey="Sciarrone M" first="M. R." last="Sciarrone">M. R. Sciarrone</name>
<name sortKey="Vairo, F" sort="Vairo, F" uniqKey="Vairo F" first="F." last="Vairo">F. Vairo</name>
</country>
<country name="Tanzanie"><noRegion><name sortKey="Fumakule, R" sort="Fumakule, R" uniqKey="Fumakule R" first="R." last="Fumakule">R. Fumakule</name>
</noRegion>
<name sortKey="Kitwa, A" sort="Kitwa, A" uniqKey="Kitwa A" first="A." last="Kitwa">A. Kitwa</name>
<name sortKey="Mangi, S" sort="Mangi, S" uniqKey="Mangi S" first="S." last="Mangi">S. Mangi</name>
<name sortKey="Mohamed, J" sort="Mohamed, J" uniqKey="Mohamed J" first="J." last="Mohamed">J. Mohamed</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000968 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000968 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:686B7C444E0A315DDEF969C7C38680C6CB07F4EE
   |texte=   The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania
}}

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania

The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri